Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL.
- Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL.
- Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).
- The audio webcast replay will be available approximately 48-hrs after the webcast.
- View source version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/